Advocacy, education and political influencing to use TRIPS safeguards to increase access to ARVs

Advocacy, education and political influencing to use TRIPS safeguards to increase access to ARVs

Project

Accion para la Salud promotes awareness on the obstacles that intellectual property rights represent for access to medicines in Peru. The project will run in liaison with organizations of PLHIV and other CSOs. The main focus for this project is a specific case against the Peruvian Government to grant a Compulsory License for atazanavir. In Perú, atazanavir costs 20 times the price paid for the generic version in neighboring countries like Bolivia. This means that the Peruvian government pays an additional amount of more than 9 million dollars per year until 2018, when the patent expires. Atazanavir represents more than 50% of the spending of the Peruvian Government on ARVs. Accion para la Salud will organize education programs for key players, develop IEC materials, involve mass media and initiate litigations.

Project details

Time frame
30 January 2015 - 29 September 2017
Budget
€ 80,000
Active in
Peru

Objectives

Main outcomes:
# Awareness of key players on the legitimacy to use safeguards such as a compulsory license (CL) to reduce the price of atazanavir
# Governmental organizations are well informed on all issues related to a CL for atazanavir
# Peruvian Government must respond in court to the demand of CSOs for a CL for atazanavir
# Consolidation of a Coalition for Access to Medicines with important CSOs from different parts of Peru
# Mass media is involved in the process to get a CL for atazanavir

Background

In Peru, 30.000 PLHIV are on treatment, 1400 on Atazanavir.

The political climate in Peru is focused on economic growth. Any measures that could affect profits of companies will scare off investors, and are therefore against the development of Peru.
Most congress people want to stay ignorant on TRIPS flexibilities because they are businessmen and have conflicting commercial interests. In 2016 general elections will be held.

Goals

< 200,000 new HIV infections globally
100%
Contributed within this project

Other projects within the programme

Fewer barriers to HIV and HCV medications for most affected in Kyrgyzstan

The Partnership Network Association (PNA) includes 26 non-governmental organizat...

Eliminating IP barriers to treatment in Malaysia

As the only registered organization in Malaysia consisting of PLHIV, Positive Ma...

2014 RfP - Eliminating intellectual property barriers

This project is part of 2014 RfP - Eliminating intellectual property barriers

In order to offer you the best website experience possible, this site places cookies on your computer.
Read more about our privacy policy and our cookie policy.